Thursday, Jul 30, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | News | Cervical Cancer Vaccine Must Be Made Part Of Immunisation Program Harish Rao

Cervical Cancer vaccine must be made part of immunisation program: Harish Rao

Along with Serum Institute (AS), the DBT on Thursday announced the launch of the indigenously made cervical cancer vaccine.

By Telangana Today
Updated On - 1 September 2022, 06:33 PM
Cervical Cancer vaccine must be made part of immunisation program: Harish Rao
File Photo
whatsapp facebook twitter telegram

Hyderabad: Health Minister, T Harish Rao on Thursday, while congratulating Department of Biotechnology (DBT) under union Ministry of Science Technology and Serum Institute for developing a vaccine for cervical cancer, hoped that it is made part of National Immunisation Program and becomes available available for free of cost for girls aged between 9 years and 14 years.

“Congratulations to Serum Institute and Department of Biotechnology for launching indigenously developed Quadrivalent Human Papillomavirus vaccine against cervical cancer. Hope it will be a part of the National immunisation program for 9-14year old girls and reach the real beneficiaries,” Health Minister on social media platform Twitter, said.

Also Read

  • India’s first vaccine against cervical cancer to come on September 1
  • Don’t ignore these 10 warning signs of Cervical Cancer
  • Cervical cancer most common after breast cancer in women: AIIMS

Along with Serum Institute (AS), the DBT on Thursday announced the launch of the indigenously made cervical cancer vaccine. According to Serum Institute CEO, Adar Poonawalla, the cervical cancer vaccine will be first made available in India and later to the other countries. The vaccine is expected to be priced anywhere between Rs. 200 and Rs. 400 and the Serum Institute is preparing to manufacture 200 million doses in the next two years.

 

  • Follow Us :
  • Tags
  • Cervical Cancer vaccine
  • Department of Biotechnology
  • Serum Institute

Related News

  • One Day One Genome initiative to harness the microbial potential of India

    One Day One Genome initiative to harness the microbial potential of India

  • Editorial: Harnessing power of biotech

    Editorial: Harnessing power of biotech

  • India working on developing vaccine for dengue

    India working on developing vaccine for dengue

  • Serum Institute developing vaccine to protect against JN.1 variant, says former ICMR DG

    Serum Institute developing vaccine to protect against JN.1 variant, says former ICMR DG

Latest News

  • Sreeshankar makes history with back-to-back CWG long jump silver

    13 mins ago
  • Bengaluru hotels warn of Swiggy boycott from Aug 15

    25 mins ago
  • US federal jury convicts Salman Rushdie’s attacker of terrorism

    38 mins ago
  • Ranbir Kapoor-Yash starrer ‘Ramayana: Part 1’ trailer unveiled in five languages

    1 hour ago
  • US launches retaliatory strikes on Iran following ‘attacks’ on American forces

    1 hour ago
  • Elon Musk’s xAI challenges Minnesota’s first-in-nation AI nudification ban

    9 hours ago
  • Trainee IPS officer threatens to leak private chats after victim marries another man

    9 hours ago
  • Mumbai police trace Sweden VPN in Aamir Khan threat probe

    9 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam